Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofarma Tbk. dan UBC Medical Indonesia Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | LABS | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 691,25 M |
Volume | — | 635,5 rb |
Lot | — | 6,36 rb |
Perputaran | — | 110,15 jt |
Harga Rata-rata | — | 173,33 |
Nilai Transaksi | — | 110,15 jt |
Harga Ekuilibrium Indikatif | — | 174 |
Volume Ekuilibrium Indikatif | — | 50 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
